MedPath
NMPA Approval

Olopatadine Hydrochloride Tablets

国药准字H20223350

February 17, 2023

Drug Information

盐酸奥洛他定片

片剂

5mg

化学药品

February 17, 2023

Company Information

Applicant Company

山西省晋城城区王台

Manufacturing Company

山西省晋城城区王台

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸奥洛他定片 - NMPA 批准文号 | MedPath